Date published: 2026-2-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLHL2 Inhibitors

KLHL2 inhibitors are a class of chemical compounds that have gained attention in the field of molecular and cellular biology. These inhibitors are designed to target and modulate the activity of KLHL2, which stands for Kelch-like protein 2. KLHL2 is a substrate-specific adaptor protein that plays a crucial role in the ubiquitin-proteasome system (UPS), a highly regulated cellular machinery responsible for the targeted degradation of proteins. It is a member of the Kelch-like family of proteins that contain Kelch repeat domains, which are known to mediate protein-protein interactions. KLHL2 acts as a substrate receptor within the Cullin-RING E3 ubiquitin ligase complex, specifically recognizing and facilitating the ubiquitination and subsequent degradation of specific target proteins. By doing so, it regulates the abundance and turnover of its substrates, impacting various cellular processes, including cell cycle progression, protein quality control, and the response to cellular stress. KLHL2 inhibitors interfere with the function or activity of KLHL2, disrupting its role in protein ubiquitination and degradation. This interference can lead to alterations in the stability of KLHL2 target proteins and impact cellular processes regulated by the UPS. Researchers employ KLHL2 inhibitors as valuable tools to investigate the specific functions and regulatory mechanisms of KLHL2 in different cellular contexts, unraveling the molecular intricacies of protein degradation pathways and their implications for cellular physiology. While the precise applications and broader implications of KLHL2 inhibitors are subjects of ongoing research, their utility in elucidating the complexities of protein turnover and degradation in cells is of paramount importance in advancing our understanding of molecular and cell biology.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

A diterpene triepoxide known to inhibit RNA polymerase II, potentially leading to decreased KLHL2 mRNA synthesis.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits RNA polymerase II transcriptional elongation, which could reduce KLHL2 mRNA levels.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor that can alter gene expression, potentially decreasing KLHL2 transcription.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

A cyclin-dependent kinase inhibitor that may suppress transcription and thereby lower KLHL2 levels.

Oxaliplatin

61825-94-3sc-202270
sc-202270A
5 mg
25 mg
$112.00
$394.00
8
(1)

Interferes with DNA replication and transcription, which could affect KLHL2 mRNA synthesis.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A DNA methyltransferase inhibitor that can change gene expression patterns, possibly impacting KLHL2 expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor known to affect various cellular proteins and may indirectly decrease KLHL2 expression by altering transcription factor levels.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Another histone deacetylase inhibitor that can change chromatin structure and gene expression, potentially affecting KLHL2.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Reversible proteasome inhibitor that can affect protein levels and may indirectly influence KLHL2 expression.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

Inhibits translation by binding to eIF4A, potentially decreasing the synthesis of KLHL2 protein.